M&A Deal Summary

Boston Scientific Acquires Lumenis Surgical Business

On March 3, 2021, Boston Scientific acquired medical products company Lumenis Surgical Business from Lumenis for 1.1B USD

Acquisition Highlights
  • This is Boston Scientific’s 41st transaction in the Medical Products sector.
  • This is Boston Scientific’s 6th largest (disclosed) transaction.
  • This is Boston Scientific’s 4th transaction in Israel.

M&A Deal Summary
Date 2021-03-03
Target Lumenis Surgical Business
Sector Medical Products
Buyer(s) Boston Scientific
Sellers(s) Lumenis
Deal Type Divestiture
Deal Value 1.1B USD

Target

Lumenis Surgical Business

Yokneam, Israel
Lumenis' Surgical Business includes premier laser systems, fibers, and accessories used for urology and otolaryngology procedures.

Search 193,711 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Boston Scientific

Marlborough, Massachusetts, United States

website

Category Company
Founded 1979
Sector Medical Products
Employees45,000
Revenue 12.7B USD (2022)
DESCRIPTION
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.
Entrance to Boston Scientific's corporate headquarters in Marlborough, Massachusetts.

Boston Scientific is a medical technology company. Boston Scientific's products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women's health, and chronic pain conditions. Boston Scientific was founded in 1979 and is based in Marlborough, Massachusetts.

DEAL STATS #
Overall 55 of 62
Sector (Medical Products) 41 of 48
Type (Divestiture) 10 of 10
Country (Israel) 4 of 4
Year (2021) 1 of 3
Size (of disclosed) 6 of 32
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-01 BTG Specialty Pharmaceuticals

Gladwyne, Pennsylvania, United States

BTG Specialty Pharmaceuticals develops, manufactures, and commercializes life-saving antidotes used in hospitals and emergency care settings, including the clinically proven and leading products CroFab®, DigiFab®, and Voraxaze®.

Sell $800M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-21 Devoro Medical

Fremont, California, United States

Devoro Medical is a developer of the WOLF Thrombectomy Platform. The innovative non-console and lytic-free WOLF technology targets and rapidly capture blood clots using finger-like prongs that retrieve and remove thrombi in the arterial and venous systems. Devoro Medical was founded in 2018 and is based in Fremont, California.

Buy -

Seller(S) 1

SELLER

Lumenis

Yokneam, Israel

website

Category Company
Founded 1991
Sector Medical Products
Employees954
Revenue 289M USD (2014)
DESCRIPTION

Lumenis Ltd. is a medical company for surgical, ophthalmology and aesthetic appliances & equipment. Lumenis was founded in 1991 and is based in Yokneam, Isreal.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
Country (Israel) 1 of 1
Year (2021) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-02 Pollogen

Greenville, Pennsylvania, United States

Pollogen Ltd. is the developer and manufacturer of five revolutionary technologies under the industry premier brand names OxyGeneo, VoluDerm, Hybrid Energy, TriPollar, TriLipo and TriFractional. It offers a full line of clinically-proven, safe and effective, non-invasive anti-aging facial and body contouring treatment platforms for a wide range of aesthetic applications.

Buy -
Mergr

Product

Company

Legal